日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ADAPT NXT: Fixed Cycles or Every-Other-Week IV Efgartigimod in Generalized Myasthenia Gravis

ADAPT NXT:固定周期或隔周静脉注射依夫加替莫德治疗全身型重症肌无力

Habib, Ali A; Claeys, Kristl G; Bril, Vera; Hussain, Yessar; Gwathmey, Kelly; Sahagian, Gregory; Cortés-Vicente, Elena; Brauer, Edward; Gelinas, Deborah; Sumbul, Anne; Jimenez, Rosa H; Hristova, Daniela; Masschaele, Delphine; Mantegazza, Renato; Meisel, Andreas; Attarian, Shahram

Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma

CheckMate 140 是一项针对复发/难治性滤泡性淋巴瘤的 2 期研究,旨在评估纳武利尤单抗的疗效和安全性。

Armand, Philippe; Janssens, Ann; Gritti, Giuseppe; Radford, John; Timmerman, John; Pinto, Antonio; Mercadal Vilchez, Santiago; Johnson, Peter; Cunningham, David; Leonard, John P; Rodig, Scott J; Martín-Regueira, Patricia; Sumbul, Anne; Samakoglu, Selda; Tang, Hao; Ansell, Stephen M

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

纳武利尤单抗联合伊匹木单抗治疗黑色素瘤伴无症状或有症状脑转移患者的安全性和有效性(CheckMate 204)

Tawbi, Hussein A; Forsyth, Peter A; Hodi, F Stephen; Lao, Christopher D; Moschos, Stergios J; Hamid, Omid; Atkins, Michael B; Lewis, Karl; Thomas, Reena P; Glaspy, John A; Jang, Sekwon; Algazi, Alain P; Khushalani, Nikhil I; Postow, Michael A; Pavlick, Anna C; Ernstoff, Marc S; Reardon, David A; Puzanov, Igor; Kudchadkar, Ragini R; Tarhini, Ahmad A; Sumbul, Anne; Rizzo, Jasmine I; Margolin, Kim A

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study

纳武利尤单抗治疗不适合或自体移植失败的复发/难治性弥漫性大B细胞淋巴瘤患者:一项单臂II期研究

Ansell, Stephen M; Minnema, Monique C; Johnson, Peter; Timmerman, John M; Armand, Philippe; Shipp, Margaret A; Rodig, Scott J; Ligon, Azra H; Roemer, Margaretha G M; Reddy, Nishitha; Cohen, Jonathon B; Assouline, Sarit; Poon, Michelle; Sharma, Manish; Kato, Kazunobu; Samakoglu, Selda; Sumbul, Anne; Grigg, Andrew

Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study.

纳武利尤单抗治疗新诊断的晚期经典霍奇金淋巴瘤:II期CheckMate 205研究的安全性和有效性

Ramchandren Radhakrishnan, Domingo-Domènech Eva, Rueda Antonio, Trněný Marek, Feldman Tatyana A, Lee Hun Ju, Provencio Mariano, Sillaber Christian, Cohen Jonathon B, Savage Kerry J, Willenbacher Wolfgang, Ligon Azra H, Ouyang Jing, Redd Robert, Rodig Scott J, Shipp Margaret A, Sacchi Mariana, Sumbul Anne, Armand Philippe, Ansell Stephen M

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma

主要组织相容性复合体II类和程序性死亡配体1表达可预测经典霍奇金淋巴瘤中程序性死亡受体1阻断后的预后

Roemer, Margaretha G M; Redd, Robert A; Cader, Fathima Zumla; Pak, Christine J; Abdelrahman, Sara; Ouyang, Jing; Sasse, Stephanie; Younes, Anas; Fanale, Michelle; Santoro, Armando; Zinzani, Pier Luigi; Timmerman, John; Collins, Graham P; Ramchandren, Radhakrishnan; Cohen, Jonathon B; De Boer, Jan Paul; Kuruvilla, John; Savage, Kerry J; Trneny, Marek; Ansell, Stephen; Kato, Kazunobu; Farsaci, Benedetto; Sumbul, Anne; Armand, Philippe; Neuberg, Donna S; Pinkus, Geraldine S; Ligon, Azra H; Rodig, Scott J; Shipp, Margaret A

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial

自体造血干细胞移植失败后复发/难治性经典霍奇金淋巴瘤患者接受纳武利尤单抗治疗:多队列单臂 II 期 CheckMate 205 试验的延长随访

Armand, Philippe; Engert, Andreas; Younes, Anas; Fanale, Michelle; Santoro, Armando; Zinzani, Pier Luigi; Timmerman, John M; Collins, Graham P; Ramchandren, Radhakrishnan; Cohen, Jonathon B; De Boer, Jan Paul; Kuruvilla, John; Savage, Kerry J; Trneny, Marek; Shipp, Margaret A; Kato, Kazunobu; Sumbul, Anne; Farsaci, Benedetto; Ansell, Stephen M